Time-dependent changes in CT of radiation-induced liver injury: A preliminary study in gastric cancer patients

Yaqi Sheng , Qiuxia Wang , Zhen Li , Nannan Zheng , Yigang Pei , Liang Chen , Dayu Hu

Current Medical Science ›› 2010, Vol. 30 ›› Issue (5) : 683 -686.

PDF
Current Medical Science ›› 2010, Vol. 30 ›› Issue (5) : 683 -686. DOI: 10.1007/s11596-010-0565-7
Article

Time-dependent changes in CT of radiation-induced liver injury: A preliminary study in gastric cancer patients

Author information +
History +
PDF

Abstract

In this study, the time-dependent changes on dynamic computed tomograph (CT) of radiation-induced liver injury in gastric cancer patients was examined. The CT images of 52 gastric cancer patients who had received chemoradiotherapies were reviewed on the PACS system. Dynamic CT scan was performed in all the subjects. Our results showed that 18 patients were found to have radiation-induced liver injury. The CT findings of radiation-induced liver injury in gastric cancer patients tend to show up one month after radiation treatment. The damaged area was of low density on all three phases, and then it was enhanced on portal vein phase or delay phase. The focal radiation reaction of liver without basic disease vanished 9–11 months later after treatment. We are led to conclude that dynamic CT is of help in the diagnosis of CRT-induced liver injury, and it may be the method of choice for following up the whole course of the CRT-induced liver injury, i.e., form hepatic damage to healing. The classification of CT findings we recommend can avoid the influence of technological factors, and thereby serve as a better guide for treatment of CRT-induced liver injury.

Keywords

chemoradiotherapy / radiation-induced liver injury / computed tomograph / gastric cancer

Cite this article

Download citation ▾
Yaqi Sheng, Qiuxia Wang, Zhen Li, Nannan Zheng, Yigang Pei, Liang Chen, Dayu Hu. Time-dependent changes in CT of radiation-induced liver injury: A preliminary study in gastric cancer patients. Current Medical Science, 2010, 30(5): 683-686 DOI:10.1007/s11596-010-0565-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

JansenE.P., BootH., VerheijM., et al.. Optimal locoregional treatment in gastric cancer. J Clin Oncol, 2005, 23(20): 4509-4517

[2]

PapachristouD.N., FortnerJ.G.. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol, 1981, 18(1): 47-53

[3]

GundersonL.L., SosinH.. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 1982, 8(1): 1-11

[4]

D’AngelicaM., GonenM., BrennanM.F., et al.. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg, 2004, 240(5): 808-816

[5]

OrdituraM., MartinelliE., GaliziaG., et al.. Chemoradiotherapy as adjuvant treatment of gastric cancer. Ann Oncol, 2007, 18(Suppl6): i133-i135

[6]

JansenE.P., BootH., DubbelmanR., et al.. Postoperative chemoradiotherapy in gastric cancer—A phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer, 2007, 97(6): 712-716

[7]

Van CutsemE., DicatoM., ArberN., et al.. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol, 2006, 17(Suppl6): i13-i18

[8]

HartgrinkH.H., van de VeldeC.J., PutterH., et al.. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol, 2004, 22(11): 2069-2077

[9]

GundersonL.L., CallisterM.D., JaroszewskiD.E., et al.. Localized gastric or gastroesophageal cancer — chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapse. Gastrointest Cancer Res, 2009, 3(2Suppl): S26-S32

[10]

CuschieriA., FayersP., FieldingJ., et al.. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet, 1996, 347(9007): 995-999

[11]

SasakoM., MaruyamaK., KinoshitaT., et al.. Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer. Jpn J Clin Oncol, 1992, 22(1): 41-48

[12]

ZhangZ.X., GuX.Z., YinW.B.. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)—report on 370 patients. Int J Radiat Oncol Biol Phys, 1998, 42(5): 929-934

[13]

Sun Y. Gastric cancer. In: National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology Version 1 (2008). (Chinese edition)

[14]

NovakJ.M., CollinsJ.T., DonowitzM., et al.. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol, 1979, 1(1): 9-39

[15]

WysockaB., KassamZ., LockwoodG., et al.. Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys, 2010, 77(1): 53-59

[16]

JeffreyR.J., MossA.A., QuiveyJ.M., et al.. CT of radiation-induced hepatic injury. AJR Am J Roentgenol, 1980, 135(3): 445-448

[17]

CaoY., PlattJ.F., FrancisI.R., et al.. The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model. Med Phys, 2007, 34(2): 604-612

[18]

MundenR.F., ErasmusJ.J., SmytheW.R., et al.. Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: an unusual CT appearance. AJR Am J Roentgenol, 2005, 184(4): 1091-1095

[19]

ClementO., MuhlerA., VexlerV.S., et al.. Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents. Radiology, 1992, 185(1): 163-168

[20]

YoshiokaaH., ItaiY., SaidaY., et al.. Superparamagnetic iron oxide-enhanced MR imaging for early and late radiation-induced hepatic injuries. Magn Reson Imaging, 2000, 18(9): 1079-1088

[21]

ReedG. J., CoxA. J.. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol, 1966, 48(4): 597-611

[22]

WillemartS., NicaiseN., StruyvenJ., et al.. Acute radiation-induced hepatic injury: evaluation by triphasic contrast enhanced helical CT. Br J Radiol, 2000, 73(869): 544-546

[23]

GarraB.S., ShawkerT.H., ChangR., et al.. The ultrasound appearance of radiation-induced hepatic injury. Correl ation with computed tomography and magnetic resonance imaging. J Ultrasound Med, 1988, 7(11): 605-609

[24]

ChiouS.Y., LeeR.C., ChiK.H., et al.. The triple-phase CT image appearance of post-irradiated livers. Acta Radiol, 2001, 42(5): 526-531

[25]

ZhuX.X., ChenL.H., WuD.H., et al.. Assessment of radiation-induced liver injury with computed tomography. Nan Fang Yi Ke Da Xue Xue Bao (Chinese), 2007, 27(1): 109-112

[26]

CromheeckeM., KoningsA.W., SzaboB.G., et al.. Liver tissue tolerance for irradiation: Experimental and clinical investigations. Hepatogastroenterology, 2000, 47(36): 1732-1740

[27]

AhmadiT., ItaiY., OnayaH., et al.. CT evaluation of hepatic injury following proton beam irradiation: appearance, enhancement, and 3D size reduction pattern. J Comput Assist Tomogr, 1999, 23(5): 655-663

AI Summary AI Mindmap
PDF

97

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/